Citation: O. Safa et al., MORPHOLOGICAL AND IMMUNOLOGICAL OBSERVATIONS ON THE EFFECTS OF HEXADECYLPHOSPHOCHOLINE (HPC) IN NUDE-MICE BEARING MT-1 BREAST-CANCER XENOGRAFTS, Anticancer research, 17(1A), 1997, pp. 37-43
Authors:
LOADMAN PM
MATTHEW AM
MCCORMICK JE
MCELHINNEY RS
BIBBY MC
Citation: Pm. Loadman et al., PHARMACOKINETICS AND ANTITUMOR-ACTIVITY OF B.4152, A REACTIVE MOLECULAR COMBINATION OF 5-FLUOROURACIL AND N-(2-CHLOROETHYL)-N-NITROSOUREA, AND ITS URACIL ANALOG, Anti-cancer drug design, 11(2), 1996, pp. 117-128
Citation: H. Sadeghialiabadi et al., STUDIES ON THE CHEMOSENSITIVITY OF HUMAN CULTURED MCF-7, MCF-7 ADR AND MT-1 BREAST-TUMORS AND K562 LEUKEMIA-CELL LINES TO NOVEL STEROIDAL ANTITUMOR PRODRUGS, British Journal of Pharmacology, 118, 1996, pp. 112-112
Citation: J. Collard et al., EO9 - RELATIONSHIP BETWEEN DT-DIAPHORASE LEVELS AND RESPONSE IN-VITROAND IN-VIVO, British Journal of Cancer, 71(6), 1995, pp. 1199-1203
Citation: Al. Laws et al., PRECLINICAL IN-VITRO AND IN-VIVO ACTIVITY OF 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID, British Journal of Cancer, 71(6), 1995, pp. 1204-1209
Authors:
MATTHEW AM
CHRISTENSSON PI
SEIDEGARD J
TUVESSON H
BIBBY MC
HARTLEYASP B
CREAVEN PJ
Citation: Am. Matthew et al., EFFECT OF DRUG SCHEDULING ON THE ANTITUMOR-ACTIVITY AND BONE-MARROW TOXICITY OF TAUROMUSTINE (TCNU), International journal of oncology, 4(2), 1994, pp. 403-409
Citation: Am. Matthew et al., PHARMACOKINETIC STUDIES OF CHLOROETHYLNITROSOCARBAMOYL-AMINO ACID-DERIVATIVES INVIVO AND INVITRO, Anticancer research, 13(1), 1993, pp. 81-86
Citation: Pm. Loadman et al., PLASMA PHARMACOKINETIC STUDIES ON B.3970, A MOLECULAR COMBINATION OF 5-FLUOROURACIL AND N-(2-CHLOROETHYL)-N-NITROSOUREA (CNU), IN A MURINE MODEL, British Journal of Pharmacology, 110, 1993, pp. 160000169-160000169